Latest Renal cell carcinoma Stories
SANTA ROSA, Calif., April 9, 2014 /PRNewswire/ -- A new study shows that honokiol,
CALGARY, April 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
- Debio 0932 demonstrated anti-tumor activity and synergy with various SOC agents in in vitro and xenograft models of NSCLC and RCC - LAUSANNE, Switzerland and LEXINGTON, Mass., April
Markets Research Reports.biz added deep and professional market research reports on "Global Cancer Vaccines Competitor Analysis And Market Research" Market Analysis and Overview.
WHIPPANY, N.J., THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 11, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
Incentives for Pathway Compliance, Reduced Hospitalization are Changing Treatment, According to Findings from Decision Resources Group BURLINGTON, Mass., March 4, 2014 /PRNewswire/ -- Decision
SAN DIEGO and OSAKA, Japan, March 4, 2014 /PRNewswire/ -- TRACON Pharmaceuticals (TRACON) and Santen Pharmaceutical Co., Ltd.
SOUTH SAN FRANCISCO, Calif., Feb.
Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Study shows impact of educational programs and clinical tools on the treatment of renal cell carcinoma RESTON, Va., Jan.